Zimmer Biomet Holdings, Inc. (ZBH) EV/EBIT Ratio: 18.50x
Is Zimmer Biomet Holdings, Inc.’s EV/EBIT ratio high or low?
Zimmer Biomet Holdings, Inc.'s EV/EBIT ratio of 18.50x is 39% below its 5-year average of 30.55x, near the low end of its 5-year range (17.24x–65.47x).
As of Saturday, June 20, 2026. 5.95% below its 12-month average of 19.67x.
ZBH EV/EBIT Ratio Chart
ZBH Average EV/EBIT Ratio Chart
ZBH Current vs Average EV/EBIT Ratio Chart
ZBH EV/EBIT Ratio Metrics
EV/EBIT RATIO
18.50x
EV/EBIT RATIO AVG TTM
19.67x
EV/EBIT RATIO AVG 3Y
21.59x
EV/EBIT RATIO AVG 5Y
29.71x
EV/EBIT RATIO AVG 10Y
33.72x
EV/EBIT RATIO AVG 15Y
29.56x
EV/EBIT RATIO AVG 20Y
24.71x
CURRENT VS TTM AVG
-5.95%
CURRENT VS 3Y AVG
-14.30%
CURRENT VS 5Y AVG
-37.74%
CURRENT VS 10Y AVG
-45.14%
CURRENT VS 15Y AVG
-37.42%
CURRENT VS 20Y AVG
-25.13%
ZBH Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $17.02B | 18.50x | 19.67x | 21.59x | 29.71x |
| Hologic, Inc. (HOLX)vs › | $16.97B | 24.28x | 22.66x | 24.05x | 18.32x |
| DaVita Inc. (DVA)vs › | $13.34B | 12.91x | 11.82x | 13.00x | 13.13x |
| Medpace Holdings, Inc. (MEDP)vs › | $13.14B | 22.74x | 28.22x | 28.07x | 28.06x |
| Solventum Corporation (SOLV)vs › | $13.06B | 8.42x | 20.55x | 17.30x | 17.30x |
| Labcorp Holdings Inc. (LH)vs › | $20.98B | 17.60x | 21.84x | 26.26x | 19.64x |
| Align Technology, Inc. (ALGN)vs › | $13.04B | 20.45x | 19.27x | 26.31x | 31.20x |
| The Cooper Companies, Inc. (COO)vs › | $12.85B | 30.48x | 23.81x | 31.75x | 35.61x |
| United Therapeutics Corporation (UTHR)vs › | $22.78B | 16.88x | 13.90x | 11.90x | 13.33x |
| Revvity, Inc. (RVTY)vs › | $11.16B | 37.96x | 35.62x | 38.74x | 31.68x |
Zimmer Biomet Holdings, Inc. EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Zimmer Biomet Holdings, Inc. EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The EV/EBIT ratio for ZBH stock is 18.50x.
- Is Zimmer Biomet Holdings, Inc.'s EV/EBIT ratio high or low?
- Zimmer Biomet Holdings, Inc.'s EV/EBIT ratio of 18.50x is 39% below its 5-year average of 30.55x, near the low end of its 5-year range (17.24x–65.47x).
- What is the TTM average EV/EBIT ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The TTM average EV/EBIT ratio for ZBH stock is 19.67x.
- What is the 3Y average EV/EBIT ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 3Y average EV/EBIT ratio for ZBH stock is 21.59x.
- What is the 5Y average EV/EBIT ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 5Y average EV/EBIT ratio for ZBH stock is 29.71x.
- What is the 10Y average EV/EBIT ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 10Y average EV/EBIT ratio for ZBH stock is 33.72x.
- What is the 15Y average EV/EBIT ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 15Y average EV/EBIT ratio for ZBH stock is 29.56x.
- What is the 20Y average EV/EBIT ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 20Y average EV/EBIT ratio for ZBH stock is 24.71x.
Zimmer Biomet Holdings, Inc. EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-18 | 18.50x |
| 2026-06-17 | 18.37x |
| 2026-06-16 | 18.70x |
| 2026-06-15 | 18.54x |
| 2026-06-12 | 18.58x |
| 2026-06-11 | 18.37x |
| 2026-06-10 | 18.53x |
| 2026-06-09 | 18.74x |
| 2026-06-08 | 18.39x |
| 2026-06-05 | 18.40x |
| 2026-06-04 | 18.30x |
| 2026-06-03 | 18.05x |
| 2026-06-02 | 17.87x |
| 2026-06-01 | 17.74x |
| 2026-05-29 | 17.65x |
| 2026-05-28 | 17.73x |
| 2026-05-27 | 17.69x |
| 2026-05-26 | 17.96x |
| 2026-05-22 | 18.13x |
| 2026-05-21 | 18.10x |
| 2026-05-20 | 18.11x |
| 2026-05-19 | 18.21x |
| 2026-05-18 | 18.07x |
| 2026-05-15 | 17.86x |
| 2026-05-14 | 17.70x |
| 2026-05-13 | 17.71x |
| 2026-05-12 | 17.81x |
| 2026-05-11 | 17.24x |
| 2026-05-08 | 17.65x |
| 2026-05-07 | 17.81x |
| 2026-05-06 | 17.73x |
| 2026-05-05 | 17.76x |
| 2026-05-04 | 17.70x |
| 2026-05-01 | 17.74x |
| 2026-04-30 | 18.89x |
| 2026-04-29 | 18.51x |
| 2026-04-28 | 18.95x |
| 2026-04-27 | 20.52x |
| 2026-04-24 | 20.31x |
| 2026-04-23 | 20.50x |
| 2026-04-22 | 20.59x |
| 2026-04-21 | 20.54x |
| 2026-04-20 | 20.99x |
| 2026-04-17 | 20.87x |
| 2026-04-16 | 20.87x |
| 2026-04-15 | 20.78x |
| 2026-04-14 | 21.15x |
| 2026-04-13 | 20.96x |
| 2026-04-10 | 20.61x |
| 2026-04-09 | 20.59x |
| 2026-04-08 | 20.59x |
| 2026-04-07 | 20.33x |
| 2026-04-06 | 20.26x |
| 2026-04-02 | 20.25x |
| 2026-04-01 | 20.27x |
| 2026-03-31 | 20.17x |
| 2026-03-30 | 19.88x |
| 2026-03-27 | 19.87x |
| 2026-03-26 | 19.97x |
| 2026-03-25 | 19.72x |
| 2026-03-24 | 19.51x |
| 2026-03-23 | 19.75x |
| 2026-03-20 | 19.76x |
| 2026-03-19 | 20.08x |
| 2026-03-18 | 19.96x |
| 2026-03-17 | 20.51x |
| 2026-03-16 | 20.63x |
| 2026-03-13 | 20.62x |
| 2026-03-12 | 20.53x |
| 2026-03-11 | 20.70x |
| 2026-03-10 | 20.38x |
| 2026-03-09 | 20.63x |
| 2026-03-06 | 20.77x |
| 2026-03-05 | 20.66x |
| 2026-03-04 | 21.03x |
| 2026-03-03 | 21.39x |
| 2026-03-02 | 21.63x |
| 2026-02-27 | 21.46x |
| 2026-02-26 | 21.87x |
| 2026-02-25 | 21.69x |
| 2026-02-24 | 21.69x |
| 2026-02-23 | 21.63x |
| 2026-02-20 | 21.51x |
| 2026-02-19 | 21.59x |
| 2026-02-18 | 19.77x |
| 2026-02-17 | 19.61x |
| 2026-02-13 | 19.51x |
| 2026-02-12 | 19.32x |
| 2026-02-11 | 19.38x |
| 2026-02-10 | 18.75x |
| 2026-02-09 | 18.50x |
| 2026-02-06 | 18.53x |
| 2026-02-05 | 18.35x |
| 2026-02-04 | 18.26x |
| 2026-02-03 | 17.97x |
| 2026-02-02 | 17.98x |
| 2026-01-30 | 18.11x |
| 2026-01-29 | 17.95x |
| 2026-01-28 | 17.90x |
| 2026-01-27 | 17.95x |
| 2026-01-26 | 18.14x |
| 2026-01-23 | 18.04x |
| 2026-01-22 | 18.18x |
| 2026-01-21 | 18.03x |
| 2026-01-20 | 18.07x |
| 2026-01-16 | 18.14x |
| 2026-01-15 | 18.36x |
| 2026-01-14 | 18.43x |
| 2026-01-13 | 18.30x |
| 2026-01-12 | 18.76x |
| 2026-01-09 | 18.97x |
| 2026-01-08 | 19.15x |
| 2026-01-07 | 18.94x |
| 2026-01-06 | 19.25x |
| 2026-01-05 | 18.94x |
| 2026-01-02 | 18.55x |
| 2025-12-31 | 18.53x |
| 2025-12-30 | 18.66x |
| 2025-12-29 | 18.62x |
| 2025-12-26 | 18.66x |
| 2025-12-24 | 18.58x |
| 2025-12-23 | 18.46x |
| 2025-12-22 | 18.51x |
| 2025-12-19 | 18.41x |
| 2025-12-18 | 18.60x |
| 2025-12-17 | 18.78x |
| 2025-12-16 | 18.68x |
| 2025-12-15 | 18.91x |
| 2025-12-12 | 18.78x |
| 2025-12-11 | 18.91x |
| 2025-12-10 | 19.01x |
| 2025-12-09 | 18.88x |
| 2025-12-08 | 18.95x |
| 2025-12-05 | 19.18x |
| 2025-12-04 | 19.02x |
| 2025-12-03 | 19.01x |
| 2025-12-02 | 19.16x |
| 2025-12-01 | 19.25x |
| 2025-11-28 | 19.67x |
| 2025-11-26 | 19.67x |
| 2025-11-25 | 19.60x |
| 2025-11-24 | 19.07x |
| 2025-11-21 | 18.87x |
| 2025-11-20 | 18.41x |
| 2025-11-19 | 18.46x |
| 2025-11-18 | 18.41x |
| 2025-11-17 | 18.34x |
| 2025-11-14 | 18.53x |
| 2025-11-13 | 18.63x |
| 2025-11-12 | 18.55x |
| 2025-11-11 | 18.32x |
| 2025-11-10 | 18.35x |
| 2025-11-07 | 18.32x |
| 2025-11-06 | 18.32x |
| 2025-11-05 | 18.18x |
| 2025-11-04 | 21.79x |
| 2025-11-03 | 21.27x |
| 2025-10-31 | 21.38x |
| 2025-10-30 | 21.22x |
| 2025-10-29 | 21.25x |
| 2025-10-28 | 21.47x |
| 2025-10-27 | 21.78x |
| 2025-10-24 | 21.77x |
| 2025-10-23 | 21.79x |
| 2025-10-22 | 21.92x |
| 2025-10-21 | 21.72x |
| 2025-10-20 | 21.72x |
| 2025-10-17 | 21.59x |
| 2025-10-16 | 21.28x |
| 2025-10-15 | 21.19x |
| 2025-10-14 | 21.04x |
| 2025-10-13 | 20.52x |
| 2025-10-10 | 20.46x |
| 2025-10-09 | 20.88x |
| 2025-10-08 | 21.03x |
| 2025-10-07 | 21.14x |
| 2025-10-06 | 21.11x |
| 2025-10-03 | 21.42x |
| 2025-10-02 | 21.16x |
| 2025-10-01 | 21.12x |
| 2025-09-30 | 21.06x |
| 2025-09-29 | 21.02x |
| 2025-09-26 | 21.02x |
| 2025-09-25 | 20.82x |
| 2025-09-24 | 21.13x |
| 2025-09-23 | 21.34x |
| 2025-09-22 | 21.57x |
| 2025-09-19 | 21.31x |
| 2025-09-18 | 21.33x |
| 2025-09-17 | 21.28x |
| 2025-09-16 | 21.15x |
| 2025-09-15 | 21.44x |
| 2025-09-12 | 21.78x |
| 2025-09-11 | 21.96x |
| 2025-09-10 | 21.65x |
| 2025-09-09 | 21.90x |
| 2025-09-08 | 22.03x |
| 2025-09-05 | 22.19x |
| 2025-09-04 | 22.04x |
| 2025-09-03 | 22.09x |
| 2025-09-02 | 22.08x |
| 2025-08-29 | 22.25x |
| 2025-08-28 | 22.09x |
| 2025-08-27 | 22.36x |
| 2025-08-26 | 22.48x |
| 2025-08-25 | 22.44x |
| 2025-08-22 | 22.51x |
| 2025-08-21 | 21.99x |
| 2025-08-20 | 22.19x |
| 2025-08-19 | 21.97x |
| 2025-08-18 | 21.70x |
| 2025-08-15 | 21.73x |
| 2025-08-14 | 21.63x |
| 2025-08-13 | 21.80x |
| 2025-08-12 | 21.58x |
| 2025-08-11 | 21.30x |
| 2025-08-08 | 21.18x |
| 2025-08-07 | 21.05x |
| 2025-08-06 | 18.29x |
| 2025-08-05 | 18.42x |
| 2025-08-04 | 18.48x |
| 2025-08-01 | 18.21x |
| 2025-07-31 | 18.36x |
| 2025-07-30 | 18.62x |
| 2025-07-29 | 18.87x |
| 2025-07-28 | 19.02x |
| 2025-07-25 | 19.26x |
| 2025-07-24 | 19.16x |
| 2025-07-23 | 19.23x |
| 2025-07-22 | 19.10x |
| 2025-07-21 | 18.51x |
| 2025-07-18 | 18.60x |
| 2025-07-17 | 18.86x |
| 2025-07-16 | 18.75x |
| 2025-07-15 | 18.73x |
| 2025-07-14 | 18.70x |
| 2025-07-11 | 18.69x |
| 2025-07-10 | 18.90x |
| 2025-07-09 | 18.90x |
| 2025-07-08 | 18.64x |
| 2025-07-07 | 18.50x |
| 2025-07-03 | 18.67x |
| 2025-07-02 | 18.64x |
| 2025-07-01 | 18.73x |
| 2025-06-30 | 18.30x |
| 2025-06-27 | 18.33x |
| 2025-06-26 | 18.38x |
| 2025-06-25 | 18.54x |
| 2025-06-24 | 18.47x |
| 2025-06-23 | 18.34x |
| 2025-06-20 | 18.30x |
| 2025-06-18 | 18.20x |
| 2025-06-17 | 18.14x |
| 2025-06-16 | 18.44x |
| 2025-06-13 | 18.31x |
| 2025-06-12 | 18.61x |
| 2025-06-11 | 18.76x |
| 2025-06-10 | 18.86x |
| 2025-06-09 | 18.54x |
| 2025-06-06 | 18.47x |
Showing the most recent 260 of 4,850 data points. The chart above shows the full history.
Related Metrics
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ivan Tornos